Granules India Limited (BOM:532482)
India · Delayed Price · Currency is INR 628.75
+20.20 (3.32%)
At close: Mar 25, 2026
Granules India Market Cap
Granules India has a market cap or net worth of 155.8 billion as of March 26, 2026. Its market cap has increased by 32.67% in one year.
Market Cap
155.80B
Enterprise Value
167.68B
Revenue
50.92B
Ranking
n/a
PE Ratio
27.96
Stock Price
628.75
Market Cap Chart
Since February 7, 2003, Granules India's market cap has increased from 163.70M to 155.80B, an increase of 95,075.46%. That is a compound annual growth rate of 34.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 155.80B | 7.27% |
| Dec 31, 2025 | 145.25B | 1.29% |
| Dec 31, 2024 | 143.40B | 45.94% |
| Dec 29, 2023 | 98.26B | 27.40% |
| Dec 30, 2022 | 77.13B | -7.49% |
| Dec 31, 2021 | 83.37B | -4.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 390.99B |
| J. B. Chemicals & Pharmaceuticals | 333.26B |
| AstraZeneca Pharma India | 207.25B |
| Jubilant Pharmova | 136.08B |
| Rubicon Research | 130.25B |
| Caplin Point Laboratories | 120.65B |
| CORONA Remedies | 96.19B |
| Viyash Scientific | 82.49B |